Key points are not available for this paper at this time.
FDA provides a useful statistical framework for settings in which the effect of covariates on the timing of activity is of interest. The use of similar models in other applications should be considered, and we make code public to facilitate this process.
Goldsmith et al. (Sat,) studied this question.